Page 1207 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

4 References

critically ill patients: a randomised controlled trial. Lancet. 105. Kalisvaart KJ, de Jonghe JF, Bogaards MJ, et al. Haloperidol
May 30, 2009;373(9678):1874-1882. prophylaxis for elderly hip-surgery patients at risk for delirium:
96. Girard TD, Pandharipande PP, Carson SS, et al. Feasibility, a randomized placebo-controlled study. J Am Geriatr Soc.
efficacy, and safety of antipsychotics for intensive care unit October 2005;53(10):1658-1666.
delirium: the MIND randomized, placebo-controlled trial. Crit 106. Rea RS, Battistone S, Fong JJ, Devlin JW. Atypical antipsychot-
Care Med. February 2010;38(2):428-437. ics versus haloperidol for treatment of delirium in acutely ill
97. Devlin JW, Roberts RJ, Fong JJ, et al. Efficacy and safety of patients. Pharmacotherapy. April 2007;27(4):588-594.
quetiapine in critically ill patients with delirium: a prospec- 107. Ray WA, Chung CP, Murray KT, Hall K, Stein CM. Atypical
tive, multicenter, randomized, double-blind, placebo-controlled antipsychotic drugs and the risk of sudden cardiac death. N Engl
pilot study. Crit Care Med. February 2010;38(2):419-427. J Med. January 15, 2009;360(3):225-235.
98. Skrobik YK, Bergeron N, Dumont M, Gottfried SB. Olanzapine 108. Meyer-Massetti C, Cheng CM, Sharpe BA, Meier CR, Guglielmo
vs haloperidol: treating delirium in a critical care setting. BJ. The FDA extended warning for intravenous haloperidol and
Intensive Care Med. March 2004;30(3):444-449. torsades de pointes: how should institutions respond? J Hosp
99. Practice guideline for the treatment of patients with delir- Med. April 2010;5(4):E8-16.
ium. American Psychiatric Association. Am J Psychiatry. May 109. Straus SM, Bleumink GS, Dieleman JP, et al. Antipsychotics
1999;156(suppl 5):1-20. and the risk of sudden cardiac death. Arch Intern Med. June 28,
100. Ely EW, Stephens RK, Jackson JC, et al. Current opinions 2004;164(12):1293-1297.
regarding the importance, diagnosis, and management of 110. Reade MC, O’Sullivan K, Bates S, Goldsmith D, Ainslie WR,
delirium in the intensive care unit: a survey of 912 healthcare Bellomo R. Dexmedetomidine vs. haloperidol in delirious,
professionals. Crit Care Med. January 2004;32(1):106-112. agitated, intubated patients: a randomised open-label trial. Crit
101. Kapur S, Remington G, Jones C, et al. High levels of dopamine Care. 2009;13(3):R75.
D receptor occupancy with low-dose haloperidol treatment: a 111. van Eijk MM, Roes KC, Honing ML, et al. Effect of rivastig-
2
PET study. Am J Psychiatry. July 1996;153(7):948-950. mine as an adjunct to usual care with haloperidol on duration
102. Seeman P. Atypical antipsychotics: mechanism of action. Can J of delirium and mortality in critically ill patients: a multicen-
Psychiatry. February 2002;47(1):27-38. tre, double-blind, placebo-controlled randomised trial. Lancet.
November 27, 2010;376(9755):1829-1837.
103. Seitz DP, Gill SS, van Zyl LT. Antipsychotics in the treatment
of delirium: a systematic review. J Clin Psychiatry. January
2007;68(1):11-21.
104. Campbell N, Boustani MA, Ayub A, et al. Pharmacological
management of delirium in hospitalized adults: a systematic
evidence review. J Gen Intern Med. July 2009;24(7):848-853.

Section06-O-ref.indd 4 12/10/2014 6:03:37 PM